Package Insert: Information for the User
Altina 1 mg Tablets EFG
Rasagilina
Read this package insert carefully before starting to take this medication because it contains important information for you.
Altina contains the active ingredient rasagilina and is indicated for the treatment of Parkinson's disease in adults. It may be used with or without levodopa (another medication used to treat Parkinson's disease).
With Parkinson's disease, there is a loss of cells that produce dopamine in the brain. Dopamine is a brain chemical involved in the control of movement. Rasagilina helps to increase and maintain dopamine levels in the brain.
Do not take Altina
Do not take the following medications while taking Altina:
You should wait at least 14 days after stopping treatment with Altina and starting treatment with MAO inhibitors or pethidine.
Warnings and precautions
Consult your doctor before starting to take Altina
Inform your doctor if you or your family/caregiver notice that you are presenting unusual behaviors in which you cannot resist the impulse, the urgent need or the anxiety to perform certain harmful or harmful activities for yourself or for others. These are called impulse control disorders. In patients taking Altina and/or other medications used to treat Parkinson's disease, behaviors such as compulsions, obsessive thoughts, ludomania, excessive spending, impulsive behavior, and an abnormally high or increased sexual impulse or thoughts or feelings have been observed. Your doctor may need to adjust or interrupt your dose (see section 4).
Altina may cause drowsiness and make you fall asleep suddenly while performing daily activities, especially if you are taking other dopaminergic medications (used to treat Parkinson's disease). If you want more information, see the section "Driving and operating machines".
Children and adolescents
The use of Altina in children and adolescents is not appropriate. Therefore, Altina is not recommended for minors under 18 years old.
Other medications and Altina
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor especially if you are taking any of the following medications:
It should be avoided to use Altina together with antidepressants containing fluoxetine or fluvoxamine.
If you are starting your treatment with Altina, you should wait at least 5 weeks since the interruption of treatment with fluoxetine.
If you are starting your treatment with fluoxetine or fluvoxamine, you should wait at least 14 days since the interruption of treatment with Altina.
Inform your doctor or pharmacist if you smoke or intend to quit smoking. Smoking may decrease the amount of Altina in the blood.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
You should avoid taking Altina if you are pregnant, as the effects of Altina on pregnancy and the fetus are unknown.
Driving and operating machines
Consult your doctor before driving or operating machines, as both Parkinson's disease and treatment with Altina may affect your ability to perform these activities. Altina may cause dizziness or drowsiness, as well as sudden sleep episodes.
This may increase if you take other medications to treat the symptoms of Parkinson's disease, if you take medications that may cause drowsiness, or if you consume alcohol during treatment with Altina. If you have experienced drowsiness and/or sudden sleep episodes before or during treatment with Altina, do not drive or operate machines (see section 2).
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose of Altina is 1 tablet of 1 mg taken by mouth, once a day.
Altina can be taken with or without food.
If you take more Altina than you should
If you think you have taken more rasagilina tablets than you should, inform your doctor or pharmacist immediately. Bring the packaging of this medication with you to show to your doctor or pharmacist.
The symptoms reported after a rasagilina overdose were mildly euphoric (mild mania), very high blood pressure, and serotonin syndrome (see section 4).
section 4).
If you forget to take Altina
Do not take a double dose to make up for the missed dose. Take the next regular dose when it is due.
If you interrupt treatment with Altina
Do not stop treatment with this medication without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Immediately contact your doctorif you experience any of the following symptoms. You may need treatment or urgent medical attention:
- If you experience unusual behaviors such as, for example, compulsions, obsessive thoughts
thoughts, excessive spending or purchases, impulsive behavior, and an abnormally high sex drive or an increase in sexual thoughts (impulse control disorders) (see section 2).
- If you see or hear things that do not exist (hallucinations).
- Any combination of hallucinations, fever, restlessness, tremors, and sweating (serotonin syndrome).
Contact your doctorif you notice any suspicious changes in your skin, as there may be an increased risk of skin cancer (melanoma) with the use of this medicine (see
section 2).
Other side effects
Very common (may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Frequency not known: cannot be estimated from available data
- High blood pressure.
- Excessive sleepiness.
- Sudden sleep.
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Usehttp://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 86°F (30°C).
Do not use this medication after the expiration date that appears on the packaging or blister after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Altina
Appearance of the product and content of the packaging
Altina is presented in the form of round, flat, white tablets.
The tablets are presented in blisters of Poliamida/Aluminio/PVC-Aluminio in containers of 30 tablets.
Holder of the marketing authorization and responsible for manufacturing
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Date of the last review of this leaflet: October 2023.
The detailed and updated information on this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.